ZNF200

gene
On this page

Summary

ZNF200 (zinc finger protein 200, HGNC:12993) is a protein-coding gene on chromosome 16p13.3, encoding Zinc finger protein 200 (P98182). Localizes protein arginine N-methyltransferase PRMT3 to the nucleus.

Predicted to enable zinc ion binding activity. Involved in protein localization to nucleus. Located in nucleus.

Source: NCBI Gene 7752 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 77 total
  • MANE Select transcript: NM_198088

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:12993
Approved symbolZNF200
Namezinc finger protein 200
Location16p13.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000010539
Ensembl biotypeprotein_coding
OMIM603231
Entrez7752

Gene structure

Transcript identifiers

Ensembl transcripts: 25 — 22 protein_coding, 3 retained_intron

ENST00000396868, ENST00000396870, ENST00000396871, ENST00000414144, ENST00000431561, ENST00000575285, ENST00000575617, ENST00000575630, ENST00000575948, ENST00000577015, ENST00000854056, ENST00000854057, ENST00000854058, ENST00000854059, ENST00000854060, ENST00000854061, ENST00000854062, ENST00000854063, ENST00000854064, ENST00000928466, ENST00000946755, ENST00000946756, ENST00000946757, ENST00000946758, ENST00000946759

RefSeq mRNA: 6 — MANE Select: NM_198088 NM_001145446, NM_001145447, NM_001145448, NM_003454, NM_198087, NM_198088

CCDS: CCDS10497, CCDS42112, CCDS45395

Canonical transcript exons

ENST00000414144 — 5 exons

ExonStartEnd
ENSE0000066649532324213232547
ENSE0000083061232335063233836
ENSE0000152655132223253224613
ENSE0000162651532349873235158
ENSE0000351726232328333232921

Expression profiles

Bgee: expression breadth ubiquitous, 238 present calls, max score 94.97.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0288 / max 91.3627, expressed in 1754 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1560174.79151655
1560161.7417855
1560151.49571007

Top tissues by expression

276 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065594.97gold quality
oocyteCL:000002392.09gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099191.52gold quality
spermCL:000001990.74gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.70gold quality
male germ cellCL:000001588.56gold quality
right testisUBERON:000453486.72gold quality
left testisUBERON:000453386.13gold quality
testisUBERON:000047385.62gold quality
bloodUBERON:000017884.59gold quality
granulocyteCL:000009482.70gold quality
endothelial cellCL:000011582.33gold quality
germinal epithelium of ovaryUBERON:000130478.40gold quality
palpebral conjunctivaUBERON:000181278.25gold quality
placentaUBERON:000198777.69gold quality
ventricular zoneUBERON:000305377.48gold quality
cortical plateUBERON:000534377.13gold quality
adrenal tissueUBERON:001830376.82gold quality
spleenUBERON:000210676.73gold quality
ganglionic eminenceUBERON:000402376.72gold quality
leukocyteCL:000073876.58gold quality
periodontal ligamentUBERON:000826676.52silver quality
tibiaUBERON:000097976.49gold quality
monocyteCL:000057676.00gold quality
mononuclear cellCL:000084275.95gold quality
epithelium of nasopharynxUBERON:000195175.92gold quality
stromal cell of endometriumCL:000225575.77gold quality
vermiform appendixUBERON:000115475.72gold quality
parietal pleuraUBERON:000240074.93gold quality
pleuraUBERON:000097774.63gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no5.09

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

94 targeting ZNF200, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-4425100.0067.591049
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-450099.9972.722367
HSA-MIR-318599.9968.121959
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-548C-3P99.9974.017587
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787
HSA-MIR-548AN99.9770.912817
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-4666A-3P99.9671.713434
HSA-LET-7D-5P99.9671.761632
HSA-MIR-445899.9671.641650
HSA-MIR-568899.9673.234504
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-548J-3P99.9472.614881

Literature-anchored findings (GeneRIF, showing 1)

  • ZNF200 is a novel binding partner of G9a. (PMID:17584299)

Cross-species orthologs

11 orthologs

OrganismSymbolGene ID
danio_reriosi:ch211-89o9.6ENSDARG00000075639
mus_musculusZfp65ENSMUSG00000071281
drosophila_melanogasterCG9609FBGN0030787
caenorhabditis_elegansWBGENE00009866
caenorhabditis_elegansM04C9.4WBGENE00010859
caenorhabditis_elegansWBGENE00011710
caenorhabditis_elegansWBGENE00012969
caenorhabditis_elegansF57C9.4WBGENE00019011
caenorhabditis_elegansWBGENE00019589
caenorhabditis_elegansWBGENE00022016
caenorhabditis_elegansWBGENE00271744

Paralogs (2): ZNF532 (ENSG00000074657), KRBOX1 (ENSG00000240747)

Protein

Protein identifiers

Zinc finger protein 200P98182 (reviewed: P98182)

All UniProt accessions (2): P98182, I3L1E4

UniProt curated annotations — full annotation on UniProt →

Function. Localizes protein arginine N-methyltransferase PRMT3 to the nucleus.

Subunit / interactions. Interacts (via C-terminus) with PRMT3 (via zinc-finger); the interaction is direct and required to localize protein arginine N-methyltransferase PRMT3 to the nucleus and inhibit its proteasomal degradation.

Subcellular location. Nucleus.

Tissue specificity. Highly expressed in testis, weakly expressed in spleen, thymus, prostate, ovary, small intestine colon and peripheral blood leukocytes.

Isoforms (3)

UniProt IDNamesCanonical?
P98182-11yes
P98182-22
P98182-33

RefSeq proteins (6): NP_001138918, NP_001138919, NP_001138920, NP_003445, NP_932353, NP_932354* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096

UniProt features (12 total): zinc finger region 5, splice variant 2, region of interest 2, chain 1, sequence variant 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P98182-F149.890.10

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 102 (showing top): MORF_BRCA1, MORF_RAD51L3, YOKOE_CANCER_TESTIS_ANTIGENS, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, MODULE_397, MORF_BCL2L11, GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS, BROWNE_HCMV_INFECTION_14HR_UP, GEORGES_TARGETS_OF_MIR192_AND_MIR215, MORF_RFC5, MORF_IL16, MORF_ERCC4, MARTENS_TRETINOIN_RESPONSE_DN, HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP, ZHANG_RESPONSE_TO_CANTHARIDIN_DN

GO Biological Process (1): protein localization to nucleus (GO:0034504)

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein localization to organelle1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

630 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF200OR1F1O43749854
ZNF200EHMT2Q96KQ7658
ZNF200ZNF280AP59817595
ZNF200MEFVO15553585
ZNF200SLC22A3O75751546
ZNF200SLC22A2O15244543
ZNF200TIGD7Q6NT04507
ZNF200MED12Q93074466
ZNF200ZNF84P51523462
ZNF200ZNF382Q96SR6453
ZNF200ZNF668Q96K58451
ZNF200ZNF487B1APH4444
ZNF200FOSBP53539430
ZNF200HEY1Q9Y5J3429
ZNF200ZNF738Q8NE65392
ZNF200RNF2Q99496392

IntAct

12 interactions, top by confidence:

ABTypeScore
FHL2ZNF200psi-mi:“MI:0915”(physical association)0.560
ZNF200FHL2psi-mi:“MI:0915”(physical association)0.560
ZNF200TASOR2psi-mi:“MI:0915”(physical association)0.500
ZNF200Dlg4psi-mi:“MI:0407”(direct interaction)0.440
CCL1ZNF200psi-mi:“MI:0915”(physical association)0.370
ZNF200PPARGC1Bpsi-mi:“MI:0915”(physical association)0.370
ZNF200SKILpsi-mi:“MI:0915”(physical association)0.370
ERHBCLAF3psi-mi:“MI:0914”(association)0.350
ZNF200ANXA13psi-mi:“MI:0914”(association)0.350
ZNF200MDM2psi-mi:“MI:0914”(association)0.350

BioGRID (15): FAM208B (Affinity Capture-MS), FAM208B (Affinity Capture-MS), ZNF200 (Affinity Capture-RNA), ZNF200 (Synthetic Lethality), FHL2 (Two-hybrid), ZNF200 (Affinity Capture-MS), GABPA (Affinity Capture-MS), FAM208B (Affinity Capture-MS), ANXA13 (Affinity Capture-MS), ZNF200 (Affinity Capture-MS), MDM2 (Affinity Capture-MS), ZNF200 (Two-hybrid), PPARGC1B (Two-hybrid), ZNF200 (Affinity Capture-RNA), ZNF200 (Two-hybrid)

ESM2 similar proteins: A0A0A6YYL3, A0JP26, A2A2Z9, A2RUR9, A6NC57, A6NI47, A6QR20, A8MYB1, A9JSR5, A9ZSY0, B2RU33, B7ZQJ9, F1M5M3, H3BUK9, O15050, P51954, P98182, Q19UN5, Q4UJ75, Q501X2, Q5CZ79, Q5DW34, Q5SQ80, Q5TYW2, Q5VUR7, Q66HB6, Q6NSI1, Q6S545, Q6S5H5, Q6S8J7, Q71S21, Q7TPV2, Q7TSC3, Q7ZT11, Q80X59, Q811D2, Q86Y13, Q86YR6, Q8IVF6, Q8IYA2

Diamond homologs: B0X9H6, O15090, O60315, P98182, Q6IQX8, Q7TSH3, Q8K083, Q92618, Q9H4T2, Q9P2Y4, Q9R0G7, Q62255, Q6NX45, Q86T29, Q8CF60, Q96LX8, Q9BXA9, Q9ER74, Q9NSC2, Q9NX65, Q9UL36, A1YEV9, A1YG26, A1YG60, A2ANX9, A2T712, A2T736, A2T7L7, A3KN32, A7Y7X5, B0K011, E9Q6W4, O14771, O15391, O35738, O43474, O62836, O95125, P08048, P0CG23

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

77 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

995 predictions. Top by Δscore:

VariantEffectΔscore
16:3224611:CTG:Cacceptor_gain1.0000
16:3224614:C:CCacceptor_gain1.0000
16:3232415:TCTTA:Tdonor_loss1.0000
16:3232416:CTTA:Cdonor_loss1.0000
16:3232417:TTACC:Tdonor_loss1.0000
16:3232418:TA:Tdonor_loss1.0000
16:3232419:A:ACdonor_gain1.0000
16:3232419:A:Cdonor_loss1.0000
16:3232419:AC:Adonor_gain1.0000
16:3232420:C:CCdonor_gain1.0000
16:3232420:CC:Cdonor_gain1.0000
16:3232545:CTC:Cacceptor_gain1.0000
16:3232546:TC:Tacceptor_gain1.0000
16:3232547:CC:Cacceptor_gain1.0000
16:3232548:C:CCacceptor_gain1.0000
16:3232548:CT:Cacceptor_loss1.0000
16:3232828:CCCA:Cdonor_loss1.0000
16:3232829:CCA:Cdonor_loss1.0000
16:3232830:CA:Cdonor_loss1.0000
16:3232831:A:ATdonor_loss1.0000
16:3232832:C:Tdonor_loss1.0000
16:3232918:TGCA:Tacceptor_gain1.0000
16:3232919:GCA:Gacceptor_gain1.0000
16:3232920:CA:Cacceptor_gain1.0000
16:3232920:CAC:Cacceptor_gain1.0000
16:3232921:AC:Aacceptor_loss1.0000
16:3232922:C:CCacceptor_gain1.0000
16:3232922:C:CGacceptor_loss1.0000
16:3232923:T:Aacceptor_loss1.0000
16:3233505:CCT:Cdonor_gain1.0000

AlphaMissense

2626 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:3224129:G:CF317L1.000
16:3224129:G:TF317L1.000
16:3224131:A:GF317L1.000
16:3224213:G:CF289L1.000
16:3224213:G:TF289L1.000
16:3224215:A:GF289L1.000
16:3224270:G:CH270Q1.000
16:3224270:G:TH270Q1.000
16:3224272:G:CH270D1.000
16:3224297:A:CF261L1.000
16:3224297:A:TF261L1.000
16:3224299:A:GF261L1.000
16:3223961:A:CF373L0.999
16:3223961:A:TF373L0.999
16:3223963:A:GF373L0.999
16:3224045:G:CF345L0.999
16:3224045:G:TF345L0.999
16:3224047:A:GF345L0.999
16:3224068:A:GC338R0.999
16:3224090:A:CH330Q0.999
16:3224090:A:TH330Q0.999
16:3224102:A:CH326Q0.999
16:3224102:A:TH326Q0.999
16:3224104:G:CH326D0.999
16:3224104:G:TH326N0.999
16:3224112:C:GR323P0.999
16:3224130:A:GF317S0.999
16:3224152:A:GC310R0.999
16:3224174:A:CH302Q0.999
16:3224174:A:TH302Q0.999

dbSNP variants (sampled 300 via entrez): RS1000144535 (16:3229527 C>A,T), RS1000326461 (16:3225056 T>C), RS1000502312 (16:3234448 G>A), RS1001046331 (16:3226130 G>A,C), RS1001072170 (16:3236807 G>C), RS1001083555 (16:3237072 A>C,G), RS1001379933 (16:3225779 C>T), RS1001539162 (16:3223469 G>C,T), RS1001690615 (16:3234678 G>A), RS1001747677 (16:3225525 T>C), RS1001967166 (16:3223589 CCA>C), RS1001983702 (16:3236729 A>G), RS1001988695 (16:3221920 A>T), RS1002009139 (16:3228033 A>C), RS1002256428 (16:3231932 G>A)

Disease associations

OMIM: gene MIM:603231 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

34 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatindecreases expression, increases expression2
Valproic Acidaffects expression, increases expression2
Aflatoxin B1increases methylation2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
sodium arseniteincreases expression1
ferrous chloridedecreases expression1
perfluorooctane sulfonic aciddecreases expression1
motexafin gadoliniumdecreases expression1
clothianidindecreases expression1
abrineincreases expression1
Temozolomideincreases expression1
Sunitinibdecreases expression1
Acetaminophenincreases expression1
Adeninedecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicincreases expression, increases methylation1
Atrazinedecreases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumincreases abundance, increases expression1
Colchicinedecreases expression1
Doxorubicindecreases expression1
Ethyl Methanesulfonateincreases expression1
Etoposidedecreases expression1
Formaldehydedecreases expression1
Methyl Methanesulfonateincreases expression1
Nickelincreases expression1
Mitomycindecreases expression1
Antirheumatic Agentsdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.